Gaithersburg-based Viela Bio Inc. has filed to go public with a $150 million initial offering.
The biotech applied to trade on the Nasdaq Global Market under the ticker symbol "VIE" and plans to offer 37,031,407 shares to the public, including 393,780 shares of unvested restricted stock subject to repurchase.
Viela did not disclose an estimated share price or net proceeds from the public offering.
In its filing, Viela disclosed that it incurred no revenue in 2018 but so far has brought in $20…
